JP:4886 Stock Latest News
Company AnnouncementsASKA Pharmaceutical Reports Higher First-Half Revenue and Operating Profit1w ago4886
Company AnnouncementsASKA Pharmaceutical Holdings Reports Revenue and Profit Growth1w ago4886
Company AnnouncementsASKA Gains Japanese Rights to Minghui’s TED Drug Candidate1w ago4886
Company AnnouncementsASKA Completes Reduced Employee Incentive Share Disposal1w ago4886
Company AnnouncementsASKA Pharmaceutical Completes Treasury Share Disposal for Restricted Stock Compensation3M ago4886
Company AnnouncementsASKA Pharmaceutical’s Q1 Profit Slumps, Full‑Year Outlook Steady3M ago4886Company AnnouncementsASKA Pharmaceutical Posts Weaker Q1 Earnings but Holds Dividend and Full-Year Guidance3M ago4886
Company AnnouncementsASKA Pharma to Grant Restricted Treasury Shares via Employee Share Plan4M ago4886
Company AnnouncementsASKA Pharma Uses Treasury Shares to Expand Performance-Linked Restricted Stock Plan4M ago4886
Company AnnouncementsASKA Pharma Wins Broad Shareholder Backing, Adopts Anti-Takeover Safeguard4M ago4886
Company AnnouncementsASKA Pharma revamps restricted share pay as it shifts to new governance structure5M ago4886
Company AnnouncementsASKA Pharmaceutical switches auditors to EY ShinNihon to support global expansion5M ago4886
Company AnnouncementsASKA Seeks Shareholder Mandate for Defense Against Potential Dalton-Led Takeover Move5M ago4886Company AnnouncementsASKA Pharma to Embed Corporate Philosophy and Shift to Audit Committee Governance5M ago4886
Company AnnouncementsASKA Pharma Corrects Pension Accounting Data Without Affecting FY2026 Earnings5M ago4886
Company AnnouncementsASKA Pharmaceutical Overhauls Board, Taps Industry Veteran for Governance Role6M ago4886
Company AnnouncementsASKA Pharmaceutical Delivers Record FY2025 Results on Overseas Expansion and Margin Gains6M ago4886- Company AnnouncementsASKA Pharmaceutical Boosts Dividend as Profits Rise but Signals Margin Pressure Ahead6M ago4886
Company AnnouncementsASKA Pharmaceutical Lifts Dividend and Adopts Progressive Payout Policy6M ago4886
Company AnnouncementsASKA Pharmaceutical Board Rejects Activist Shareholder’s Director Proposal6M ago4886Company AnnouncementsASKA sets 2035 long-term vision and unveils 2028 medium-term growth plan7M ago4886